Section four – NHS trust pressures

In recent years, NHS trusts have faced increasing pressures; the cost of providing services has risen faster than their income. This has resulted in a growing overall deficit since 2013/14. This trend was reversed in 2016/17. Although NHS trusts still posted an overall deficit of £806m, this was a large improvement on the deficit of £2.5bn in 2015/16 (Figure 7). However, it was higher than the planned deficit for the year of £591m.

The STF was a significant contributor to the reduced deficits with £1.8bn allocated as income to NHS trusts, directly from NHS England. Without the STF the overall provider deficit may have been higher than in 2015/16, at a potential £2.6bn. However, this figure may be misleading, as at least part of the funding that came from the STF would have been available to trusts if funding was allocated differently (see Chapter 5 for more detail).

Some figures in this section are presented with and without the STF for reference, as well as to provide a range of what may have happened without the STF. For example, Figure 7 shows that if the STF had been provided as regular income in 2016/17, the overall deficit would have been somewhere between £806m and £2.6bn.

Figure 7: Net financial position of NHS trusts, 2012/13–2017/18 (2017/18 prices)

Figure 7: Net financial position of NHS trusts, 2012/13–2017/18 (2017/18 prices)

Note: 2017/18 figure is the year-end forecast figure for 2017/18 per NHS Improvement Q3 2017/18 performance report.

Source: NHS Improvement Quarterly Performance Reports, Health Foundation analysis

The STF improved the net position of trusts, as the funding could not be used in the current year. This means it directly reduced the deficit of those in the red, while increasing the surplus of those in the black.

There was also a reduction in the number of trusts posting a deficit, thus breaking the trend of growing numbers of trusts doing so since 2012/13. 44% of trusts posted a deficit in 2016/17 compared with 67% in 2015/16 – this was the lowest level since 2013/14 (Figure 8). With the STF excluded from the calculation, the proportion of trusts in deficit remained almost the same as in 2015/16, at 66%.

Figure 8: Percentage of trusts in deficit, 2012/13–2017/18

Figure 8: Percentage of trusts in deficit, 2012/13–2017/18


Source: NHS Improvement Quarterly Performance Reports, Health Foundation analysis

At Q3 2017/18, the in-year deficit was £1.3bn, against a plan of £916m. This was due in part to overspends of £701m on employee costs and £292m on non-staff costs. The deficit is forecast to fall by the end of 2017/18 to £931m, but this would still be an increase on the 2016/17 deficit, and would be much higher than the planned deficit of £496m.

Most of the change in trusts’ position was caused by a significant decline in the deficit position of acute trusts, which fell from £2.7bn in 2015/16 to £1.2bn in 2016/17. Mental health trusts ended the year in the largest surplus, at £165m, followed by specialist trusts, with an £81m surplus. The ambulance sector also ended the year in a deficit position, though this was smaller than in 2015/16.

Table 1: Trusts’ net adjusted surplus/deficit by sector, 2012/13–2016/17 (2017/18 prices)

2012/13

2013/14

2014/15

2015/16

2016/17

Acute

£198m (17%)

-£452m (76%)

-£1,064m (65%)

-£2,670m (88%)

-£1,185m (61%)

Ambulance

£19m (9%)

£16m (50%)

£14m (20%)

-£12m (40%)

£0m (30%)

Mental health

£270m (18%)

£191m (21%)

£101m (28%)

£56m (39%)

£165m (21%)

Community

£32m (0%)

£42m (16%)

£15m (16%)

£18m (26%)

£11m (17%)

Specialist

£127m (0%)

£118m (28%)

£65m (50%)

£70m (50%)

£81m (24%)

TOTAL

£593m

-£112m

-£-868m

£-2,538m

-£806m

† – figure includes impact of adjustments by NHSI improvement of £121m, for changes in provider status, and change in discount rate provision.

Source: NHS Improvement quarterly performance reports and Health Foundation analysis

Growth in total income and costs

Over 90% of NHS trusts’ total income is received via CCGs and NHS England, predominantly in the form of payment for patient care activities. Although total costs were still higher than income in 2016/17, growth in total income (£3.1bn, 3.9%) was higher than growth in total costs (£1.5bn, 1.8%) for the first time (Figure 9). This meant that the provider deficit fell by 68% from £2.5bn in 2015/16.

Growth in income was largely due to the introduction of the £1.8bn STF. This funding was intended to improve the financial position of trusts, and as it could not be spent on additional services, it did not lead to any additional costs. This is discussed further in Chapter 5.

Figure 9: England NHS trusts’ total costs and total income, 2015/16 and 2016/17 (2017/18 prices)

Figure 9: England NHS trusts’ total costs and total income, 2015/16 and 2016/17 (2017/18 prices)

Note: Total costs and income refer to all costs and income per NHS Improvement quarterly performance reports. The difference between total costs and income does not exactly match the overall deficit due to adjustments made at a national level.

Source: NHS Improvement Quarterly Performance Reports

The amounts that trusts are paid for activity through the national payment by results (PbR) tariff increased in cash terms for the first time since 2010/11. Each year the tariff is uplifted to reflect increased costs due to costs of pay, drugs, capital, Clinical Negligence Scheme for Trusts (CNST), and other operating costs. In 2016/17 the total cost increase was estimated to be 3.1%. An efficiency factor is applied to this increase, to incentivise trusts to improve their cost effectiveness. In previous years the factor has been set higher than the estimated cost increase, resulting in a cash-terms fall in prices. In 2016/17 the efficiency factor was set at 2%, so prices rose by an average of 1.1% in cash terms.

Acute trusts saw the largest increase in operating income (4.9%) compared to operating costs (2.2%) in 2016/17. Operating income for community trusts fell by 3%, while their costs fell by 2.7%. Operating income for mental health trusts rose by 1.3%, while their costs increased by 0.3%.

Ambulance trusts saw the largest percentage increase in operating costs, at 3.5%, compared to an increase in income of 4%. Excluding the STF, operating income and costs rose by 2.2%. For all other provider types, operating costs rose by more – or decreased by less – than operating income, if the STF is excluded (Figure 10).

Figure 10: Percentage change in operating costs and income by NHS provider type in England, with and without the STF, 2015/16–2016/17 (2017/18 prices)

Figure 10: Percentage change in operating costs and income by NHS provider type in England, with and without the STF, 2015/16–2016/17 (2017/18 prices)

Source: NHS Improvement Quarterly Performance Reports, Health Foundation analysis

Cost pressures for NHS trusts

The increased operating costs of NHS trusts were predominantly driven by increases of £1.1bn in permanent staff costs, £330m in temporary staff and £290m drug costs (see Figure 11).

These were balanced by a 19.6% fall in agency costs (£760m). This is a reverse of the recent trend of rising agency costs, following the introduction of the control measures by NHS Improvement due to significant rising expenditures in prior years. As a result, agency costs accounted for 6% of total staff costs in 2016/17, compared to 7.6% in 2015/16.

Cost improvement programmes had a significant impact on current year costs in 2016/17 – there were £3.2bn of cost improvements, reflecting 3.7% of total spend by trusts. Of these, approximately 75% were recurrent savings, meaning they would result in savings in future years.

The remaining 25% were one-off, or non-recurrent, savings – this figure is much higher than the planned portion of 8%. This trend has continued in 2017/18, with a forecast at Q3 of 3.8% of total spend in efficiency savings, with 78% being recurrent and 22% non-recurrent. One-off savings are again forecast to be much higher (134%) than plan. This continues an ongoing trend of over-reliance on one-off savings to improve the financial position each year.

Figure 11: Changes in operating costs of NHS trusts, 2015/16–2016/17 (£bn, 2017/18 prices)

Figure 11: Changes in operating costs of NHS trusts, 2015/16–2016/17
(£bn, 2017/18 prices)

Note: Figures relate to operating costs, rather than total costs.

Source: Financial accounts of trusts and NHS Improvement data.

Staff costs

Staff costs continue to be the most significant cost for trusts, at more than 60% of overall operating costs. In 2016/17, total staff costs rose by £674m (1.3%), which was smaller than the increase of 3.5% in 2015/16. Permanently employed staff make up 90% of total staff costs (Figure 12).

Figure 12: Total staff costs in English NHS trusts by staff type, 2015/16 and 2016/17 (£bn, 2017/18 prices)

Figure 12: Total staff costs in English NHS trusts by staff type, 2015/16 and 2016/17 (£bn, 2017/18 prices)

Source: Health Foundation analysis


Figure 13 shows the change in costs by staff type. The cost of permanent employees contributed most of the total change, at £1.1bn – an increase of 2.5%. The greatest relative increase was for other temporary staff, at 18.2% (£331m). Agency staff costs fell by 19.5% in 2016/17; however, spending was still 23.5% over the plan for the year.

Figure 13: Annual change in staff cost by staff type, 2015/16–2016/17 (£bn and %, 2017/18 prices)

Figure 13: Annual change in staff cost by staff type, 2015/16–2016/17 (£bn and %, 2017/18 prices)

Source: Health Foundation analysis

In 2016/17, there was a 1% increase in staff numbers on a whole-time equivalent (WTE) basis, while total staff costs rose by 1.3%. Most of the rise in staff costs was therefore due to an increase in staff numbers, rather than an increase in average staff cost per worker. Since 2010, average NHS pay increases have been below that of the private sector. For nurses and health visitors, this means they are earning approximately 5% less than they would be had their wages risen at the same rate as the private sector. However, while trusts managed to keep pay costs growing at 1.3%, total pay costs were still £826m higher than plan, reflecting the tight cost controls in place for staff costs.

Drug costs

Drug costs rose by 4.2%, from £6.8bn in 2015/16 to £7.1bn in 2016/17 (see Figure 14). This growth rate is lower than that seen in 2015/16 (12%) and 2014/15 (6%). Spending on drugs in 2016/17 was 2.1% higher than planned.

Figure 14: Annual prescription drug spend in NHS Trusts, 2013/14–2016/17 (% and £bn, 2017/18 prices)

Figure 14: Annual prescription drug spend in NHS Trusts, 2013/14–2016/17 (% and £bn, 2017/18 prices)

Source: Health Foundation analysis

Spending on drugs by sector has been changing, with hospitals accounting for 48% of total drug costs in 2016/17, compared to 32% in 2010/11 (see Figure 15). This was due to an average increase in hospital drug spend of 10.3% between 2010/11 and 2016/17, and an average fall in primary care prescribing spend of 1.0%. This was driven by newer and more expensive medicines being used more in hospitals than primary care, and a greater use of drugs in specialist hospitals.

Figure 15: Estimated share of total spending on drugs in hospital, primary care and community sectors, 2010/11–2016/17

Figure 15: Estimated share of total spending on drugs in hospital, primary care and community sectors, 2010/11–2016/17

Note: Figures refer to ‘net ingredient costs’ of drugs excluding VAT. Hospital prescribing dispensed in the community refers to drug prescriptions written in hospital but dispensed in the community. Net Ingredient costs refers to the basic cost of a drug as used in primary care, but does not necessarily reflect the final price paid for drugs, as providers may individually negotiate different prices.

Source: NHS Digital 2017


‡‡‡ The efficiency factor is set by NHS Improvement to reflect the expected improvements made by NHS providers to deliver services at a lower cost.

§§§ These are estimated figures based on the net ingredient costs of drugs excluding VAT, and include high-cost drugs and drugs in the drug tariff. For hospitals, the figures do not necessarily represent what was paid by the hospitals, as NHS contracts provide discounts on many products.

Previous Next